Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for zilucoplan (Zilbrysq) for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody-positive.